NDAOPHTHALMICSOLUTION/DROPS
Approved
Jun 1994
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 6h ago · AI intelligence enriched 3w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
OPCON-A is a fixed-dose ophthalmic solution combining pheniramine maleate (antihistamine) and naphazoline hydrochloride (decongestant) for topical eye use. It treats allergic conjunctivitis and ocular congestion by reducing histamine-mediated inflammation and vasodilation. This combination targets both allergic symptoms and vascular hyperemia in the conjunctiva.
LOE Approaching
As a mature product approaching loss of exclusivity with moderate competitive pressure (30%), the brand team is likely consolidating rather than expanding, signaling smaller teams and defensive positioning.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on OPCON-A offers limited career growth due to its mature LOE-approaching lifecycle and modest linked job count. Roles focus on defending market share and managing legacy product profitability rather than innovation or expansion, making this suitable for operational excellence or transition roles.
Brand ManagerField Sales Representative
Worked on OPCON-A at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.